Calidi Biotherapeutics Stock Volatility
| CLDI Stock | 0.76 0.06 7.32% |
Calidi Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3 % return per unit of risk over the last 3 months. Calidi Biotherapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Calidi Biotherapeutics' Risk Adjusted Performance of (0.20), standard deviation of 3.47, and Mean Deviation of 2.58 to double-check the risk estimate we provide.
Sharpe Ratio = -0.3048
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLDI |
Based on monthly moving average Calidi Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Calidi Biotherapeutics by adding Calidi Biotherapeutics to a well-diversified portfolio.
Key indicators related to Calidi Biotherapeutics' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Calidi Biotherapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Calidi daily returns, and it is calculated using variance and standard deviation. We also use Calidi's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Calidi Biotherapeutics volatility.
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Calidi Biotherapeutics at lower prices. For example, an investor can purchase Calidi stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes. Main indicators related to Calidi Biotherapeutics' market risk premium analysis include:
Beta 1.36 | Alpha (1.00) | Risk 3.5 | Sharpe Ratio (0.30) | Expected Return (1.07) |
Moving together with Calidi Stock
| 0.89 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.89 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
| 0.94 | ABP | Abpro Holdings | PairCorr |
| 0.79 | QSI | QuantumSi | PairCorr |
| 0.9 | GNLX | Genelux Common | PairCorr |
| 0.77 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.92 | KURA | Kura Oncology | PairCorr |
| 0.89 | LYRA | Lyra Therapeutics | PairCorr |
| 0.87 | MBIO | Mustang Bio | PairCorr |
| 0.86 | MREO | Mereo BioPharma Group | PairCorr |
| 0.88 | PRQR | ProQR Therapeutics Earnings Call This Week | PairCorr |
| 0.87 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
Moving against Calidi Stock
| 0.72 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.69 | ENGN | enGene Holdings Common | PairCorr |
| 0.63 | DSGN | Design Therapeutics | PairCorr |
| 0.47 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.42 | KYTX | Kyverna Therapeutics | PairCorr |
Calidi Biotherapeutics Market Sensitivity And Downside Risk
Calidi Biotherapeutics' beta coefficient measures the volatility of Calidi stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Calidi stock's returns against your selected market. In other words, Calidi Biotherapeutics's beta of 1.36 provides an investor with an approximation of how much risk Calidi Biotherapeutics stock can potentially add to one of your existing portfolios. Calidi Biotherapeutics exhibits very low volatility with skewness of -0.55 and kurtosis of 1.13. Calidi Biotherapeutics is a potential penny stock. Although Calidi Biotherapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Calidi Biotherapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Calidi instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
| α | -1 | β | 1.36 | Check current 90 days Calidi Biotherapeutics correlation with market (Dow Jones Industrial)
Calidi Biotherapeutics Volatility and Downside Risk
Calidi standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Calidi Biotherapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Calidi Biotherapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Calidi Biotherapeutics' price changes. Investors will then calculate the volatility of Calidi Biotherapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Calidi Biotherapeutics' volatility:
Historical Volatility
This type of stock volatility measures Calidi Biotherapeutics' fluctuations based on previous trends. It's commonly used to predict Calidi Biotherapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Calidi Biotherapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Calidi Biotherapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Calidi Biotherapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Calidi Biotherapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.3617 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Calidi Biotherapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Calidi Biotherapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Calidi Biotherapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Calidi stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a Calidi Biotherapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Calidi Biotherapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Calidi Biotherapeutics is -328.11. The daily returns are distributed with a variance of 12.21 and standard deviation of 3.49. The mean deviation of Calidi Biotherapeutics is currently at 2.58. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.81
α | Alpha over Dow Jones | -1 | |
β | Beta against Dow Jones | 1.36 | |
σ | Overall volatility | 3.50 | |
Ir | Information ratio | -0.28 |
Calidi Biotherapeutics Stock Return Volatility
Calidi Biotherapeutics historical daily return volatility represents how much of Calidi Biotherapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.495% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7767% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Calidi Stock performing well and Calidi Biotherapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Calidi Biotherapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CMND | 7.14 | (4.01) | 0.00 | 2.09 | 0.00 | 11.60 | 56.34 | |||
| CANF | 5.06 | (0.60) | 0.00 | 0.45 | 0.00 | 10.40 | 38.42 | |||
| KZIA | 8.15 | (0.18) | 0.01 | 0.03 | 10.28 | 14.69 | 78.79 | |||
| TTNP | 3.46 | 0.25 | 0.03 | 1.30 | 5.38 | 9.38 | 30.41 | |||
| SILO | 3.72 | (0.73) | 0.00 | (0.28) | 0.00 | 8.33 | 24.79 | |||
| CNSP | 3.59 | (0.80) | 0.00 | (0.99) | 0.00 | 7.22 | 31.54 | |||
| SXTP | 7.94 | 1.17 | 0.09 | (0.15) | 7.69 | 10.44 | 166.26 | |||
| XBIO | 3.13 | (0.10) | 0.00 | (0.05) | 0.00 | 4.96 | 20.89 | |||
| QLGN | 5.09 | (0.59) | 0.00 | 2.34 | 0.00 | 10.42 | 26.37 | |||
| SNGX | 3.46 | (0.40) | 0.00 | (0.16) | 0.00 | 8.16 | 30.10 |
About Calidi Biotherapeutics Volatility
Volatility is a rate at which the price of Calidi Biotherapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Calidi Biotherapeutics may increase or decrease. In other words, similar to Calidi's beta indicator, it measures the risk of Calidi Biotherapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Calidi Biotherapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 1.1 M | 1.6 M | |
| Market Cap | 27.9 M | 26.5 M |
Calidi Biotherapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Calidi Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Calidi Biotherapeutics' price varies over time.
3 ways to utilize Calidi Biotherapeutics' volatility to invest better
Higher Calidi Biotherapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Calidi Biotherapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Calidi Biotherapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Calidi Biotherapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Calidi Biotherapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Calidi Biotherapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Calidi Biotherapeutics Investment Opportunity
Calidi Biotherapeutics has a volatility of 3.5 and is 4.49 times more volatile than Dow Jones Industrial. 31 percent of all equities and portfolios are less risky than Calidi Biotherapeutics. You can use Calidi Biotherapeutics to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of Calidi Biotherapeutics to be traded at 0.722 in 90 days.Pay attention - limited upside
The correlation between Calidi Biotherapeutics and DJI is -0.79 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Calidi Biotherapeutics and DJI in the same portfolio, assuming nothing else is changed.
Calidi Biotherapeutics Additional Risk Indicators
The analysis of Calidi Biotherapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Calidi Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Calidi Biotherapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.20) | |||
| Market Risk Adjusted Performance | (0.65) | |||
| Mean Deviation | 2.58 | |||
| Coefficient Of Variation | (388.60) | |||
| Standard Deviation | 3.47 | |||
| Variance | 12.03 | |||
| Information Ratio | (0.28) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Calidi Biotherapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Calidi Biotherapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Calidi Biotherapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Calidi Biotherapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Calidi Biotherapeutics.
Complementary Tools for Calidi Stock analysis
When running Calidi Biotherapeutics' price analysis, check to measure Calidi Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calidi Biotherapeutics is operating at the current time. Most of Calidi Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Calidi Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calidi Biotherapeutics' price. Additionally, you may evaluate how the addition of Calidi Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |